概要
NRG Therapeutics develops small molecule treatments for severe neurodegenerative conditions including amyotrophic lateral sclerosis, motor neurone disease and Parkinson's. The company is preparing to move into clinical trials following pre-clinical data. The financing funds clinical proof of concept in ALS and MND plus clinical data generation in Parkinson's patients. Headquartered in Stevenage.
資金調達
| ラウンド |
金額 |
発表日 |
投資家 |
|
Series B
|
会員限定 |
会員限定 |
投資家 7社 |